To access this element change to forms mode OFF

Archived Grant Opportunity View - GO4453

MRFF 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists Grant Opportunity

Contact Details

:
13 28 46

:

:

GO ID:
GO4453
Agency:
Department of Health
Close Date & Time:
23-Feb-2021 5:00 pm (ACT Local Time)
Show close time for other time zones
Internal Reference ID:
MRFF
Primary Category:
231013 - Medical Research
Secondary Category:
381003 - Academic Medical Research
Publish Date:
10-Nov-2020
Location:
ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Selection Process:
Open Competitive

FO Reference:

Description:

The 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists grant opportunity is part of the Medical Research Future Fund (MRFF) and the Preventive and Public Health Research Initiative.

It will support research to

  • test innovative public health approaches
  • identify innovative approaches to treat and manage chronic and complex diseases
  • improve the quality and cost-effectiveness of preventive healthcare interventions

It will provide grants to support medical research and innovation projects that create or adapt:

  • technologies
  • mechanisms
  • approaches

Projects should aim to improve medicine use and medicine intervention by pharmacists in primary health and transitions of care. They should target improvements to quality, safety and effectiveness. The projects should also align with relevant peak or representative bodies to help national implementation.

Intended outcomes

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians. 

It will promote the safe and effective use of medicines, particularly in high-risk groups and settings such as:

  • the elderly
  • people with complex chronic diseases
  • rural and remote communities
  • Aboriginal and Torres Strait Islander peoples
  • culturally and linguistically diverse people and communities
  • aged care facilities

It also aims to reduce adverse drug events and medicine-related hospital admissions.

Eligibility:

To be eligible you must:

  • have an Australian business number (ABN)
  • be incorporated in Australia

You must also be one of the following entities:

  • a medical research institute
  • a university 
  • a corporate Commonwealth entity 
  • a corporation (including businesses and not for profits)
  • a state or territory government
  • a state or territory government entity

We encourage joint applications provided you have a lead organisation who is the main driver of the project and is eligible to apply.

We can only accept applications where you can provide:

  • details of your nominated Chief Investigator A (CIA), the person who will take the lead role in conducting the project
  • details of all members of your research team are listed as Chief Investigators (CIs)
  • evidence from your board (or chief executive officer or equivalent if there is no board) that the project is supported, and that you can complete the project and meet the costs of the project not covered by grant funding
  • letters of support from each project partner, where applicable
Total Amount Available (AUD):

$13,000,000.00

Estimated Grant Value (AUD):

From $0.00 to $2,500,000.00

Instructions for Application Submission:
Other Instructions:

business.gov.au provides information and advice to businesses via a range of channels including phone (13 28 46), email and web chat. Contact us for assistance.

Contact Details

:
13 28 46

:

: